Shijiazhuang Yiling Pharmaceutical Co: Net profit rose 26% to ¥669 million despite a 12% revenue drop, with strong cash flow

About this update from Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

Revenue fell 12.26% YoY to ¥4.04 billion, but net profit jumped 26.03% to ¥669 million, driven by improved margins and strong cash flow. Heart/cerebrovascular and respiratory products remain core, while R&D investment and new product launches support future growth.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A